XML 33 R22.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders’ Equity (Tables)
9 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Schedule of RSUs activity
          
   Number of
Shares
   Weighted-Average Grant Date
Fair Value
per Share
 
   (In thousands)      
Balance of RSUs outstanding at June 30, 2024   1,881   $4.89 
Granted   1,413    3.37 
Forfeited   (391)   4.19 
Vested   (726)   5.05 
Balance of RSUs outstanding at March 31, 2025   2,177   $3.97 
Schedule of PSUs activity
     
   Number of Shares 
   (In thousands) 
Balance of PSUs outstanding at June 30, 2024   1,669 
Granted   583 
Forfeited   (588)
Vested   (669)
Balance of PSUs outstanding at March 31, 2025   995 
Schedule of option activity
          
   Number of Shares   Weighted-Average Exercise Price
per Share
 
   (In thousands)      
Balance of options outstanding at June 30, 2024   567   $4.13 
Forfeited   (15)   5.46 
Expired   (14)   2.19 
Exercised   (230)   3.36 
Balance of options outstanding at March 31, 2025   308   $4.74 
Schedule of employee stock purchase plan
     
   Number of 
   Shares 
   (In thousands) 
Shares available for issuance at June 30, 2024  $181 
Shares issued   (84)
Shares available for issuance at March 31, 2025  $97 
Schedule of share-based compensation expense
                    
   Three Months Ended   Nine Months Ended 
   March 31,   March 31, 
   2025   2024   2025   2024 
   (In thousands) 
Cost of revenue  $34   $66   $146   $171 
Selling, general and administrative   1,159    1,337    3,329    4,238 
Research and development   324    469    1,155    1,381 
Total share-based compensation expense  $1,517   $1,872   $4,630   $5,790 
Schedule of unrecognized share-based compensation expense
          
   Remaining Unrecognized Compensation Expense   Remaining Weighted-Average Years To Recognize 
   (In thousands)      
Stock options  $106    1.8 
RSUs   7,297    2.2 
PSUs   2,694    1.9 
Stock purchase rights under ESPP   19    0.1 
   $10,116